Common Diseases

Question 0

FBS cutoff value

Answer 0

7.0 mmol/L or 126 mg/dL

Question 1

HBa1c cutoff for DM

Answer 1

6.5%

Question 2

Dosage of atenolol

Answer 2

25, 50, 100

Question 3

Treatment for dyspepsia

Answer 3

Omeprazole 20-40 mg OD

Question 4

Treatment for heliobacter pylori

Answer 4

Clarithromycin 500 mg bid

Question 5

Nonphysiologic jaundice?

Answer 5

First 24 hours of life

Question 6

Asia pacific obesity cutoffs

Answer 6

25 obese

Question 7

Screening for GDM at how many weeks?

Answer 7

24 weeks

Question 8

Screening for DM 2 indicated in?

Answer 8

Patients with a BP of 135/80 mmHg

Question 9

Hypertension stages

Answer 9

Stage 1-140/90

Stage 2- 160/100

Question 10

Hypertensive emergency BP and management?

Answer 10

180/120 -> lower to 25% of map

Question 11

Recommended treatment for UTI acute uncomplicated cystitis

Answer 11

Nitrofurantoin 100mg BID 5 days

Fosfomycin 3g in 1/2 glass of water

Question 12

Acute pyelonephritis treatment

Answer 12

Ceftriaxone 1g IM IV one dose

Question 13

UTI in pregnant women tested for when?

Answer 13

9-17 weeks

Question 14

Treatment for UTI in pregnancy?

Answer 14

Nitro (not near term), co Amox and cotrimox

Question 15

How many specimens for sputum afb?

Answer 15

Three

Question 16

as classification of tb px?

Answer 16

0- no exposure, 1- exposed no infection, 2- exposed no disease, 3- exposed clinically active, 4- exposed not clinically active, 5- tb suspect

Question 17

Treatment for tb relapse

Answer 17

2 hrze plus one hrze plus 5 hre

Question 18

In the absence of risk criteria DM screening should begin at age?

Answer 18

45

Question 19

Treatment for low risk cap

Answer 19

Amoxicillin or macrolides for atypical pathogens in well px, Amox or ceph plus Mac

Question 20

Treatment for moderate risk cap

Answer 20

Blic + Mac or blic + fq

Question 21

5 elements of tb dots

Answer 21

Political commitment with increased and sustained financing, case detection through quality-assured bacteriology, standardized treatment with supervision and patient support, an effective drug supply and management system, monitoring and evaluation system and impact measurement